These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3363225)

  • 1. Pharmacokinetics of high and moderate intravenous doses of methotrexate.
    Awidi A; al-Turk A; Madanat F; Othman S; Shaheen O
    Res Commun Chem Pathol Pharmacol; 1988 Mar; 59(3):411-4. PubMed ID: 3363225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of biological variables upon pharmacokinetic parameters of intramuscular methotrexate in rheumatoid arthritis.
    Debord J; Carpentier N; Sabot C; Bertin P; Marquet P; Treves R; Merle L; Lachâtre G
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):227-30. PubMed ID: 9587050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of urinary excretion of methotrexate (MTX) in patients with malignant tumors].
    Skibińska L
    Pol Tyg Lek; 1992 Jun 15-29; 47(24-26):545-8. PubMed ID: 1480527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of small doses of methotrexate in patients with psoriasis.
    Kamel RS; al-Hakiem MH; Rademaker M; Meyrick Thomas RH; Munro DD
    Acta Derm Venereol; 1988; 68(3):267-70. PubMed ID: 2455425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in nontoxic patients after lumbar injection.
    Bleyer WA; Dedrick RL
    Cancer Treat Rep; 1977 Jul; 61(4):703-8. PubMed ID: 577895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 2- and 3-compartment models for the Bayesian estimation of methotrexate pharmacokinetics.
    Sabot C; Debord J; Roullet B; Marquet P; Merle L; Lachatre G
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):164-9. PubMed ID: 7599915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.
    Mok TS; Kanekal S; Lin XR; Leung TW; Chan AT; Yeo W; Yu S; Chak K; Leavitt R; Johnson P
    Cancer; 2001 Jun; 91(12):2369-77. PubMed ID: 11413527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of fluorouracil in humans.
    MacMillan WE; Wolberg WH; Welling PG
    Cancer Res; 1978 Oct; 38(10):3479-82. PubMed ID: 688233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate.
    Breithaupt H; Küenzlen E
    Cancer Treat Rep; 1982 Sep; 66(9):1733-41. PubMed ID: 6956440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate: bioavailability and pharmacokinetics.
    Campbell MA; Perrier DG; Dorr RT; Alberts DS; Finley PR
    Cancer Treat Rep; 1985; 69(7-8):833-8. PubMed ID: 3893694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A significant methotrexate-glutamine pharmacokinetic interaction.
    Charland SL; Bartlett DL; Torosian MH
    Nutrition; 1995; 11(2):154-8. PubMed ID: 7647480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sufentanil pharmacokinetics in young adult and elderly surgical patients.
    Helmers JH; van Leeuwen L; Zuurmond WW
    Eur J Anaesthesiol; 1994 May; 11(3):181-5. PubMed ID: 8050423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life-threatening interaction between the root extract of Pueraria lobata and methotrexate in rats.
    Chiang HM; Fang SH; Wen KC; Hsiu SL; Tsai SY; Hou YC; Chi YC; Chao PD
    Toxicol Appl Pharmacol; 2005 Dec; 209(3):263-8. PubMed ID: 15936791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of methotrexate in the guinea pig.
    Schlatter J; Di Blasi-Bouvet S; Raynaud F; Cisternino S
    Cell Mol Biol (Noisy-le-grand); 1999 May; 45(3):363-8. PubMed ID: 10386793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of palifermin administered as the standard dose and as a collapsed dose in patients with hematologic malignancies.
    Zia-Amirhosseini P; Hurd DD; Salfi M; Cheah TC; Aycock J; Cesano A
    Pharmacotherapy; 2007 Oct; 27(10):1353-60. PubMed ID: 17896890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of high-dose methotrexate in Japanese adult patients with malignancies: a concurrent analysis of the serum and urine concentration data.
    Fukuhara K; Ikawa K; Morikawa N; Kumagai K
    J Clin Pharm Ther; 2008 Dec; 33(6):677-84. PubMed ID: 19138246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of azithromycin after single- and multiple-doses in children.
    Stevens RC; Reed MD; Shenep JL; Baker DK; Foulds G; Luke DR; Blumer JL; Rodman JH
    Pharmacotherapy; 1997; 17(5):874-80. PubMed ID: 9324176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of selenium administered parenterally at toxic doses in sheep.
    Blodgett DJ; Bevill RF
    Am J Vet Res; 1987 Mar; 48(3):530-4. PubMed ID: 3565910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of vincristine sulfate in adult cancer patients.
    Sethi VS; Jackson DV; White DR; Richards F; Stuart JJ; Muss HB; Cooper MR; Spurr CL
    Cancer Res; 1981 Sep; 41(9 Pt 1):3551-5. PubMed ID: 7260915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of treprostinil sodium administered by 28-day chronic continuous subcutaneous infusion.
    Wade M; Baker FJ; Roscigno R; DellaMaestra W; Arneson CP; Hunt TL; Lai AA
    J Clin Pharmacol; 2004 May; 44(5):503-9. PubMed ID: 15102871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.